1. Home
  2. UTMD vs KRRO Comparison

UTMD vs KRRO Comparison

Compare UTMD & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Utah Medical Products Inc.

UTMD

Utah Medical Products Inc.

HOLD

Current Price

$67.88

Market Cap

235.3M

Sector

Health Care

ML Signal

HOLD

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

SELL

Current Price

$13.98

Market Cap

204.1M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
UTMD
KRRO
Founded
1978
2014
Country
United States
United States
Employees
N/A
57
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
235.3M
204.1M
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
UTMD
KRRO
Price
$67.88
$13.98
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
★ $20.20
AVG Volume (30 Days)
31.5K
★ 186.7K
Earning Date
10-22-2026
11-11-2026
Dividend Yield
★ 1.80%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 1.66
N/A
Revenue
★ $38,520,000.00
$6,392,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$56.67
P/E Ratio
$41.77
★ N/A
Revenue Growth
N/A
★ 181.46
52 Week Low
$53.66
$5.20
52 Week High
$76.89
$42.70

Technical Indicators

Market Signals
Indicator
UTMD
KRRO
Relative Strength Index (RSI) 22.57 70.98
Support Level $66.40 $9.43
Resistance Level $72.81 $14.69
Average True Range (ATR) 1.28 1.05
MACD -0.83 0.62
Stochastic Oscillator 2.32 97.51

Price Performance

Historical Comparison
UTMD
KRRO

About UTMD Utah Medical Products Inc.

Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: